# Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Trial

> **NCT00619775** · PHASE3 · COMPLETED · sponsor: **Medtronic Endovascular** · enrollment: 419 (actual)

## Conditions studied

- Carotid Artery Disease

## Interventions

- **DEVICE:** PROTÉGÉ® GPS™ and PROTÉGÉ® RX Carotid Stent Systems and Spider Embolic Protection Device

## Key facts

- **NCT ID:** NCT00619775
- **Lead sponsor:** Medtronic Endovascular
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-04
- **Primary completion:** —
- **Final completion:** 2005-10
- **Target enrollment:** 419 (ACTUAL)
- **Last updated:** 2021-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00619775

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00619775, "Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00619775. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*